Task: Answer the multiple-choice question.
Question: Which drug exhibits a 23.603% human ether-à-go-go related gene (hERG) inhibition at 10uM?
Constraint: You must select none, one or more options from a or b without using any additional words.
Options:
a Cc1ccccc1Nc1nc(-c2sc(NC(=O)c3ccco3)nc2C)cs1
b CC(C)CC(COCc1cccc(Cl)c1)N1CCN(C(=O)c2ccc(C(F)(F)F)cc2)CCC1=O
Answer: a. Cc1ccccc1Nc1nc(-c2sc(NC(=O)c3ccco3)nc2C)cs1
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
Cc1ccccc1Nc1nc(-c2sc(NC(=O)c3ccco3)nc2C)cs1
Cc1ccccc1Nc1nc(-c2sc(NC(=O)c3ccco3)nc2C)cs1
N-[4-methyl-5-[2-(2-methylanilino)-1,3-thiazol-4-yl]-1,3-thiazol-2-yl]furan-2-carboxamide